Early supplementation with live combined Bacillus subtilis and Enterococcus faecium: association with feeding intolerance and gut microbiota composition in antibiotic-exposed preterm infants
Frühe Supplementierung mit lebender kombinierter Bacillus subtilis- und Enterococcus faecium-Präparation: Zusammenhang mit Nahrungsintoleranz und Darmmikrobiota bei antibiotikaexponierten Frühgeborenen
Frontiers in Cellular and Infection Microbiology · 19.05.2026 · 16
DOI: 10.3389/fcimb.2026.1826157 ↗Auf einen Blick
Bei 79 antibiotikaexponierten Frühgeborenen war frühe LCBE-Supplementierung mit weniger Nahrungsintoleranz verbunden. Gleichzeitig zeigten sich günstigere Veränderungen der Darmmikrobiota.
Fragestellung
Ist frühe LCBE-Supplementierung bei antibiotikaexponierten Frühgeborenen mit einer geringeren Nahrungsintoleranz und veränderter Darmmikrobiota assoziiert?
Methode
Prospektive Beobachtungsstudie bei 79 Frühgeborenen auf der NICU; Einteilung nach klinischer LCBE-Gabe in Probiotika- und Nicht-Probiotika-Gruppe; 16S-rRNA-Sequenzierung von 274 Stuhlproben.
Ergebnisse
Nahrungsintoleranz: 17,07 % vs. 44,74 %; adjustierte OR 0,156 (95 %-KI 0,050–0,491; p = 0,001). Der Zusammenhang zeigte sich erst in den postnatalen Tagen 21–28.
Schlussfolgerung der Autor:innen
Bei antibiotikaexponierten Frühgeborenen war frühe LCBE-Supplementierung mit weniger Nahrungsintoleranz verbunden; die Autoren berichten zudem günstige Effekte auf die Darmmikrobiota.
Kernaussagen
- 17,07 % vs. 44,74 % Nahrungsintoleranz unter LCBE vs. ohne Probiotika
- Adjustierte OR 0,156 (95 %-KI 0,050–0,491)
- Keine behandlungsbedingten unerwünschten Ereignisse berichtet
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.05.2026. Verfasst von Chaohui Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Institution, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Enterococcus faecium, Probiotics, Gastrointestinal Microbiome, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Background
Early antibiotic exposure frequently induces gut dysbiosis in preterm infants. Although probiotics, such as the live combined preparation of Bacillus subtilis and Enterococcus faecium (LCBE), may mitigate this disruption, high-quality clinical evidence in this high-risk population remains limited. This prospective observational study investigated the association of early LCBE supplementation with the incidence of feeding intolerance (FI) and gut microbiota composition in antibiotic-exposed preterm infants.
Methods
Seventy-nine antibiotic-exposed preterm infants admitted to the neonatal intensive care unit (NICU) between February 2020 and April 2022 were enrolled and divided into two groups based on clinical LCBE administration: the probiotic group (n = 41) and the non-probiotic group (n = 38). Clinical data were collected prospectively. Gut microbiota composition was analyzed via 16S rRNA gene sequencing of 274 fecal samples (144 from the probiotic group, 130 from the non-probiotic group).
Results
LCBE supplementation was associated with a significantly lower incidence of FI (17.07% vs. 44.74%; adjusted OR = 0.156, 95% CI: 0.050–0.491, p = 0.001). Notably, this protective association became evident only during the post-supplementation period (postnatal days 21–28), suggesting a delayed but sustained effect. The intervention was well-tolerated, with no treatment-related adverse events reported. In infants receiving LCBE, we observed suppression of potentially pathogenic bacteria, including Enterococcus and Klebsiella , alongside the preservation of beneficial genera such as Bifidobacterium and Lactobacillus . These microbial shifts were accompanied by a more stable and mature gut microbiota profile.
Conclusions
In antibiotic-exposed preterm infants, early LCBE supplementation was associated with a significant reduction in the incidence of feeding intolerance. This clinical benefit was accompanied by favorable gut microbiota modulation, characterized by the suppression of opportunistic pathogen overgrowth and the preservation of beneficial commensal taxa. These findings support the potential role of LCBE as a safe and well-tolerated adjunctive intervention in this vulnerable population, offering practical insights for neonatologists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Trial Institution, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Neonatal Intensive Care Unit, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
- School of Bioengineering, East China University of Science and Technology, Shanghai, China.
Zitieren
APA
Ye, C., Li, L., Zhang, H., Lyu, Q., Xu, Y., & Li, Y. (2026). Early supplementation with live combined Bacillus subtilis and Enterococcus faecium: association with feeding intolerance and gut microbiota composition in antibiotic-exposed preterm infants. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1826157
Vancouver
Ye C, Li L, Zhang H, Lyu Q, Xu Y, Li Y. Early supplementation with live combined Bacillus subtilis and Enterococcus faecium: association with feeding intolerance and gut microbiota composition in antibiotic-exposed preterm infants. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1826157
BibTeX
@article{Ye2026,
author = {Ye, Chaohui and Li, Li and Zhang, Hongming and Lyu, Qin and Xu, Yinquan and Li, Yanhong},
title = {Early supplementation with live combined Bacillus subtilis and Enterococcus faecium: association with feeding intolerance and gut microbiota composition in antibiotic-exposed preterm infants},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1826157}
}
EUVIMED